Valuation: Sumitomo Pharma Co., Ltd.

Capitalization 1,156B 7.31B 6.26B 5.82B 5.43B 10.14B 659B 10.88B 67.07B 26.36B 315B 27.42B 26.86B P/E ratio 2026 *
12.5x
P/E ratio 2027 * 12.9x
Enterprise value 1,337B 8.46B 7.24B 6.74B 6.28B 11.74B 762B 12.59B 77.6B 30.5B 365B 31.72B 31.07B EV / Sales 2026 *
3.09x
EV / Sales 2027 * 2.52x
Free-Float
42.39%
Yield 2026 *
-
Yield 2027 * 0.43%
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.89%
1 week+14.81%
Current month+21.89%
1 month+26.00%
3 months+64.85%
6 months+173.79%
Current year+21.89%
More quotes
1 week 2,439
Extreme 2439
2,955
1 month 2,207
Extreme 2207
2,955
Current year 2,352
Extreme 2352
2,955
1 year 500
Extreme 500
2,955
3 years 279
Extreme 279
2,955
5 years 279
Extreme 279
2,955
10 years 279
Extreme 279
4,135
More quotes
Manager TitleAgeSince
Chief Executive Officer 65 25/06/2024
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/04/2022
Director TitleAgeSince
Director/Board Member 64 25/06/2025
Director/Board Member 65 01/06/2016
Director/Board Member 61 01/06/2018
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-2.89%+14.81%+411.87%+213.25% 7.31B
+1.64%+3.79%+35.14%+201.01% 968B
+2.61%+2.65%+47.63%+20.53% 505B
-0.02%-0.06%+25.62%+44.55% 389B
-0.86%+4.33%+28.20%+17.53% 367B
-0.77%+4.74%+29.53%+22.45% 295B
-1.21%+1.63%+10.02%-2.31% 271B
-0.14%+4.79%+25.23%+35.16% 274B
+1.60%+11.02%-37.21%-15.74% 263B
-0.17%+1.50%+24.14%+20.16% 175B
Average -0.11%+6.00%+60.02%+55.66% 351.55B
Weighted average by Cap. +0.24%+3.76%+26.79%+69.77%
See all sector performances

Financials

2026 *2027 *
Net sales 433B 2.74B 2.35B 2.18B 2.03B 3.8B 247B 4.08B 25.13B 9.88B 118B 10.27B 10.06B 500B 3.16B 2.71B 2.52B 2.35B 4.39B 285B 4.7B 29B 11.4B 136B 11.86B 11.61B
Net income 92.2B 583M 499M 464M 433M 809M 52.56B 868M 5.35B 2.1B 25.15B 2.19B 2.14B 89.9B 569M 487M 453M 422M 789M 51.25B 846M 5.22B 2.05B 24.52B 2.13B 2.09B
Net Debt 181B 1.15B 983M 914M 852M 1.59B 103B 1.71B 10.53B 4.14B 49.5B 4.31B 4.22B 101B 640M 548M 509M 475M 887M 57.66B 952M 5.87B 2.31B 27.58B 2.4B 2.35B
More financial data * Estimated data
Logo Sumitomo Pharma Co., Ltd.
Sumitomo Pharma Co Ltd, formerly Sumitomo Dainippon Pharma Co Ltd, is a Japan-based pharmaceutical company. The Company operates its business through four segments. The Japan segment is engaged in the manufacture, purchase, and sale of ethical drugs. The North American segment is engaged in the manufacture, purchase, and sale of ethical drugs and conducts research and development in the areas of oncology, urology, respiratory disease, and regenerative cell medicine. The China segment is engaged in the manufacture (small packaged products) and sale of ethical pharmaceuticals. The Overseas Others segment is engaged in the manufacture and sale of ethical pharmaceuticals in Europe. The segment also purchase and sell ethical pharmaceuticals in Southeast Asia and Taiwan, as well as provide information and collection activities for the Company's products. Other business includes manufacturing, purchasing, and sales of food ingredients, food additives and chemical product materials.
Employees
3,832
More about the company
Date Price Change Volume
13/01/26 2,825.50 ¥ -2.89% 14,026,700
09/01/26 2,909.50 ¥ +2.48% 15,460,500
08/01/26 2,839.00 ¥ +7.80% 24,199,000
07/01/26 2,633.50 ¥ +4.40% 7,943,700
06/01/26 2,522.50 ¥ +2.50% 8,914,900

Delayed Quote Japan Exchange, 13 January 2026 at 05:30 pm AEDT

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
2,909.50JPY
Average target price
2,158.33JPY
Spread / Average Target
-25.82%
Consensus

Quarterly revenue - Rate of surprise